hiPSC-Derived Cells as Models for Drug Discovery 2.0

Rivka Ofir

doi:10.3390/ijms24065727

hiPSC-Derived Cells as Models for Drug Discovery 2.0

Int J Mol Sci. 2023 Mar 17;24(6):5727. doi: 10.3390/ijms24065727.

Author

Rivka Ofir^{1

2}

Affiliations

¹ The Regenerative Medicine and Stem Cell (RMSC) Research Center, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
² Dead Sea & Arava Science Center, Masada 8691000, Israel.

Abstract

Human-induced pluripotent stem cells (hiPSCs) serve as a sustainable resource for studying the molecular foundation of disease development, including initiation and deterioration [...].

Publication types

Editorial

MeSH terms

Cell Differentiation
Drug Discovery
Fibroblasts
Humans
Induced Pluripotent Stem Cells*

Grants and funding

This research was funded by The Ministry of Innovation Science and Technology, Israel grant number Merkava 100342.